ResearcherZhongda Hospital Southeast UniversityNo recent work listed

Hai-Feng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9380-7879; OpenAlex author ID A5101602015. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Survival prediction for patients with malignant biliary obstruction caused by pancreatic cancer undergoing biliary drainage: the COMBO-PaS model. Co-author DOI 10.1007/s00464-022-09698-6 ↗
Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer. Co-author DOI 10.3389/fonc.2019.00973 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hai‐Bin Shi · 1 shared paper, 2023 · strength 0.18
- Paper Survival prediction for patients with malignant biliary obstruction caused by pancreatic cancer undergoing biliary drai… DOI 10.1007/s00464-022-09698-6 ↗
Wei‐Fu Lv · 1 shared paper, 2019 · strength 0.08
- Paper Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer. DOI 10.3389/fonc.2019.00973 ↗
Gao‐Jun Teng · 1 shared paper, 2019 · strength 0.08
- Paper Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer. DOI 10.3389/fonc.2019.00973 ↗
Jie Tian · 1 shared paper, 2019 · strength 0.08
- Paper Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer. DOI 10.3389/fonc.2019.00973 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.